Gene · 25937
Papers2,228
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,228
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Identification of Functional Modules and Key Pathways Associated with Innervation in Graft Bone-CGRP Regulates the Differentiation of Bone Marrow Mesenchymal Stem Cells via p38 MAPK and Wnt6/β-Catenin. | Stem Cells Int | 2023 | 37621747 | PubTator, text mining | PubMed |
| Targeting sulfation-dependent mechanoreciprocity between matrix and osteoblasts to mitigate bone loss. | Sci Transl Med | 2023 | 37611084 | PubTator, text mining | PubMed |
| Primary hepatic epithelioid hemangioendothelioma masquerading as metastases: A rare case report. | Radiol Case Rep | 2023 | 37609067 | PubTator, text mining | PubMed |
| Substrate topographies modulate the secretory activity of human bone marrow mesenchymal stem cells. | Stem Cell Res Ther | 2023 | 37605275 | PubTator, text mining | PubMed |
| Hepatic epithelioid hemangioendothelioma-a single-institution experience with 51 cases. | Front Oncol | 2023 | 37601682 | PubTator, text mining | PubMed |
The impact of interaction between verteporfin and yes-associated protein 1/transcriptional coactivator with PDZ-binding motif-TEA domain pathway on the progression of isocitrate dehydrogenase wild-type glioblastoma. | J Cent Nerv Syst Dis | 2023 | 37600236 | PubTator, text mining | PubMed |
| The circadian clock protein Cryptochrome 1 is a direct target and feedback regulator of the Hippo pathway. | iScience | 2023 | 37593458 | PubTator, text mining | PubMed |
| Portal Hypertension in Nonalcoholic Fatty Liver Disease: Challenges and Paradigms. | J Clin Transl Hepatol | 2023 | 37577237 | PubTator, text mining | PubMed |
| The role of the FSGS disease gene product and nuclear pore protein NUP205 in regulating nuclear localization and activity of transcriptional regulators YAP and TAZ. | Hum Mol Genet | 2023 | 37565816 | PubTator, text mining | PubMed |
| Epithelioid haemangioendothelioma-a rare cause of right pleural effusion and multiple primary nodules: Case report & review of the literature. | JRSM Open | 2023 | 37560747 | PubTator, text mining | PubMed |
| Composite haemangioendothelioma in the heart: a case report. | Eur Heart J Case Rep | 2023 | 37559782 | PubTator, text mining | PubMed |
| Regulatory mechanisms and therapeutic implications of insulin-like growth factor 2 mRNA-binding proteins, the emerging crucial m6A regulators of tumors. | Theranostics | 2023 | 37554271 | PubTator, text mining | PubMed |
| Endothelial TAZ inhibits capillarization of liver sinusoidal endothelium and damage-induced liver fibrosis via nitric oxide production. | Theranostics | 2023 | 37554269 | PubTator, text mining | PubMed |
| Synaptopodin-2: a potential tumor suppressor. | Cancer Cell Int | 2023 | 37544991 | PubTator, text mining | PubMed |
| Cardiomyocyte proliferation is suppressed by ARID1A-mediated YAP inhibition during cardiac maturation. | Nat Commun | 2023 | 37543677 | PubTator, text mining | PubMed |
| The Utility of Fine Needle Aspiration (FNA) Biopsy in the Diagnosis of Mediastinal Lesions. | Diagnostics (Basel) | 2023 | 37510144 | PubTator, text mining | PubMed |
| The new world of RNA diagnostics and therapeutics. | J Exp Clin Cancer Res | 2023 | 37507791 | PubTator, text mining | PubMed |
| Serine/Threonine Protein Kinase-3 Promotes Oral Squamous Cell Carcinoma by Activating Ras-MAPK Mediated Cell Cycle Progression. | Int J Gen Med | 2023 | 37496599 | PubTator, text mining | PubMed |
| Spontaneous urinary bladder regeneration after subtotal cystectomy increases YAP/WWTR1 signaling and downstream BDNF expression: Implications for smooth muscle injury responses. | PLoS One | 2023 | 37494380 | PubTator, text mining | PubMed |
| Therapeutically targeting essential metabolites to improve immunometabolism manipulation after liver transplantation for hepatocellular carcinoma. | Front Immunol | 2023 | 37492564 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25937/papers?page=13